Ariel V. Dowling, PhD is an Associate Director of Digital Clinical Devices within the Data Sciences Institute at Takeda Pharmaceuticals. In this role, Ariel oversees the assessment and deployment of digital clinical devices and platforms in clinical studies and related activities across the organization. Prior to joining Takeda, she was a Senior Clinical Data Scientist at Biogen Inc where she oversaw the analysis of data from wearable sensors deployed in drug development clinical trials for Parkinson's Disease. She also developed digital sensor implementation protocols, risk mitigation strategies, and data analysis plans for devices deployed across the company in Phase I and II clinical trials. Prior to Biogen, Ariel was the algorithm team lead at MC10 Inc, where she oversaw the development and implementation of algorithms across the full product line and managed all aspects of algorithm testing that lead to a successful FDA submission. She has also worked as a senior research scientist at BioSensics LLC, where she designed algorithms to analyze digital device data from Huntington's disease patients, stroke patients, and wheelchair users. Ariel holds an MS and PhD in Mechanical Engineering from Stanford University and a BE in Mechanical Engineering from Dartmouth College. She was also a post-doctoral research fellow at the Technion-Israel Institute of Technology.
Transforming the Life Sciences through Digital Health